Cargando…
GABAergic Neurotransmission in Human Tissues Is Modulated by Cannabidiol
Recently, the potential use of phytocannabinoids (pCBs) to treat different pathological conditions has attracted great attention in the scientific community. Among the different pCBs, cannabidiol (CBD) has showed interesting biological properties, making it a promising molecule with a high security...
Autores principales: | Ruffolo, Gabriele, Gaeta, Alessandro, Cannata, Beatrice, Pinzaglia, Camilla, Aronica, Eleonora, Morano, Alessandra, Cifelli, Pierangelo, Palma, Eleonora |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9786817/ https://www.ncbi.nlm.nih.gov/pubmed/36556407 http://dx.doi.org/10.3390/life12122042 |
Ejemplares similares
-
Phytocannabinoids in Neurological Diseases: Could They Restore a Physiological GABAergic Transmission?
por: Cifelli, Pierangelo, et al.
Publicado: (2020) -
Unexpected Effect of IL-1β on the Function of GABA(A) Receptors in Pediatric Focal Cortical Dysplasia
por: Alfano, Veronica, et al.
Publicado: (2022) -
Dissecting the Molecular Determinants of GABA(A) Receptors Current Rundown, a Hallmark of Refractory Human Epilepsy
por: Cifelli, Pierangelo, et al.
Publicado: (2021) -
Modulation of GABAergic dysfunction due to SCN1A mutation linked to Hippocampal Sclerosis
por: Ruffolo, Gabriele, et al.
Publicado: (2020) -
GABA(A) receptor function is enhanced by Interleukin-10 in human epileptogenic gangliogliomas and its effect is counteracted by Interleukin-1β
por: Ruffolo, Gabriele, et al.
Publicado: (2022)